Spirapril – a modern ACE inhibitor

QR Code

Spirapril – a modern ACE inhibitor

An ACE inhibitor, spirapril, is widely used in modern cardiology practice. Its pharmacokinetics is characterized by prolonged elimination half-life, >24 hours. There is no need for dose titration, even in patients with chronic renal failure. The medication is effective in treating individuals...

Full description

Saved in:

Bibliographic Details
Main Author:	V. M. Gorbunov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2005-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	spirapril chronic renal failure chronic heart failure arterial hypertension
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/978
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure
by: S, Yu. Volkova, et al.
Published: (2006-08-01)

ACE inhibitor spirapril effects on circadian blood pressure profile, quality of life, and psychological status in patients with Stage I-II arterial hypertension
by: V. M. Gorbunov, et al.
Published: (2008-12-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

The effect of hypertension, diabetes, and smoking on the levels of some biochemical parameters in chronic renal failure patients
by: Noor H. Ali, et al.
Published: (2019-05-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (1970-01-01)

ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01)

SPIRAPRIL EFFECTS ON OFFICE AND AMBULATORY BLOOD PRESSURE LEVELS AND THEIR DIFFERENCE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2009-02-01)

Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2007-08-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

Arterial hypertension as a heart failure predictor in patients with chronic glomerulonephritis and intact renal function
by: N. Yu. Borovkova, et al.
Published: (2009-10-01)

Hypertensive encephalopathy, heart remodeling, and chronic heart failure
by: L. A. Geraskina, et al.
Published: (2006-06-01)

CHARACTERISTICS OF THE CHRONIC HEART FAILURE COURSE AND TARGET ORGAN CONDITION IN CARDIORENAL SYNDROME
by: I. I. Kolegova, et al.
Published: (2018-03-01)

Lercanidipine in patients with chronic renal failure: the ZAFRA Study
by: N. R. Robles, et al.
Published: (2010-08-01)

SELECTION OF THE OPTIMAL ANTIHYPERTENSION TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE WITH THE SIGNS OF CHRONIC KIDNEY DISEASE
by: N. Yu Borovkova, et al.
Published: (2016-12-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

MICROCIRCULATION IN CHRONIC HEART FAILURE PATIENTS TREATED WITH ACE INHIBITORS AND DIURETICS
by: Yu. I. Gurfinkel, et al.
Published: (2011-04-01)

Chronic heart failure in out-patient practice: aetiology issues
by: S. M. Bogdanova, et al.
Published: (2008-08-01)

Torasemide – loop diuretic with specific effects
by: V. M. Gorbunov, et al.
Published: (2006-10-01)

COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension
by: S. N. Tereshchenko, et al.
Published: (2010-04-01)

MALIGNANT HYPERTENSION WITH PREDOMINANT KIDNEY DAMAGE
by: N. D. Lapochkina, et al.
Published: (2018-05-01)

Cryoablation method for pulmonary artery sympathetic denervation in patients with pulmonary hypertension secondary to left sided heart disease: interventional technique, safety and results of the hospital phase
by: D. A. Feshchenko, et al.
Published: (2019-09-01)

Clinical traits of chronic heart failure in patients with arterial hypertension and senile asthenia syndrome: an observational cross-sectional study
by: V. A. Safronenko, et al.
Published: (2021-08-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

IC Class medications in patients with atrial fibrillation, arterial hypertension, chronic heart failure and intact systolic function
by: O. N. Miller, et al.
Published: (2008-08-01)

Are there benefits of low doses of ACE inhibitors, MRAs, diuretics and statins in the treatment of heart failure?
by: V. А. Lysenko
Published: (2021-07-01)

Personal Characteristics and Adaptation Mechanisms of Patients with Arterial Hypertension and Chronic Heart Failure
by: E. V. Efremova, et al.
Published: (2021-01-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

The role of calcium metabolism dysregulation in the pathogenesis of cardiovascular diseases
by: D. E. Mailian, et al.
Published: (2019-09-01)

ГИПЕРТРОФИЧЕСКАЯ КАРДИОМИОПАТИЯ И СОЧЕТАННАЯ КАРДИОЛОГИЧЕСКАЯ ПАТОЛОГИЯ : ОСОБЕННОСТИ ДИАГНОСТИКИ И ЛЕЧЕНИЯ
by: С. С. Якушин, et al.
Published: (2011-02-01)

Pharmaco-economical analysis of Russian QUADRIGA Study data
by: A. A. Kuprina, et al.
Published: (2006-04-01)

Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01)

SUCCESSFUL TREATMENT OF CARDIORENAL SYNDROME: A CLINICAL CASE OF HEART TRANSPLANTATION IN A PATIENT WITH DILATED CARDIOMYOPATHY AND ACUTE RENAL PATHOLOGY
by: Yu. V. Kovaleva, et al.
Published: (2012-08-01)

Serum Erythropoietin in Patients with Chronic Renal Failure in the Predialysis Stage
by: Adelaida Ruseva, et al.
Published: (2023-12-01)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
by: M. A. Efremovtseva, et al.
Published: (2008-08-01)

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01)

LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

NOVEL COMBINATION OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITOR PERINDOPRIL AND HIGHLY SELECTIVE β-ADRENOBLOCKER BISOPROLOL: PRIME AMONG THE EQUAL
by: O. D. Ostroumova, et al.
Published: (2018-06-01)